Document Detail


Decongestant use during pregnancy and its association with preterm delivery.
MedLine Citation:
PMID:  20672347     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Despite the frequent intake of decongestants during pregnancy, only one study to date has evaluated the association of decongestants with preterm delivery, and it identified a reduced risk. We examined this association in more detail.
METHODS: Using a population-based random sample of 3271 Massachusetts live-born births without major malformations, we categorized decongestant exposure according to timing, frequency of use, route, and indication. Preterm birth was defined as a gestational age of <37 completed weeks. We estimated hazard ratios and examined confounding by indication by examining various strata of women and through multivariate adjustment.
RESULTS: Compared to nonexposed women, those who took decongestants during the second or third trimester only were less likely to experience preterm delivery (HR, 0.42; 95% CI, 0.21-0.84). This association was observed only for women without preeclampsia.
CONCLUSIONS: A protective association between decongestant use and preterm delivery has now been observed in two studies; however, the possibility of confounding by underlying condition remains.
Authors:
Rohini K Hernandez; Allen A Mitchell; Martha M Werler
Related Documents :
8659657 - The risk of prematurity and small-for-gestational-age birth in mexico city: the effects...
8728087 - Pregnancy after the fontan procedure for tricuspid atresia. a case report.
8912997 - Antibiotic therapy for preterm premature rupture of the membranes.
14712947 - Association between first trimester maternal serum pregnancy associated plasma protein-...
8887237 - New formula for estimating fetal weight below 1000 g: comparison with existing formulas.
6743577 - Exposure to solvents and outcome of pregnancy in university laboratory employees.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Birth defects research. Part A, Clinical and molecular teratology     Volume:  88     ISSN:  1542-0760     ISO Abbreviation:  Birth Defects Res. Part A Clin. Mol. Teratol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-27     Completed Date:  2011-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101155107     Medline TA:  Birth Defects Res A Clin Mol Teratol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  715-21     Citation Subset:  IM    
Copyright Information:
© 2010 Wiley-Liss, Inc.
Affiliation:
Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts 02118, USA. rohinikh@bu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cohort Studies
Confounding Factors (Epidemiology)
Delivery, Obstetric
Female
Gestational Age
Humans
Massachusetts
Nasal Decongestants / therapeutic use*
Obstetric Labor, Premature*
Parturition / drug effects*
Phenylpropanolamine / therapeutic use
Pregnancy
Pregnancy Trimester, First
Pregnancy Trimester, Second
Pregnancy Trimester, Third
Pseudoephedrine / therapeutic use
Questionnaires
Retrospective Studies
Rhinitis / drug therapy*
Risk Factors
Chemical
Reg. No./Substance:
0/Nasal Decongestants; 14838-15-4/Phenylpropanolamine; 90-82-4/Pseudoephedrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The visceral yolk sac endoderm provides for absorption of nutrients to the embryo during neurulation...
Next Document:  Reduction in cadmium-induced toxicity and c-Jun N-terminal kinase activation by glutathione in cultu...